Table 4. Comparison of SIRT1 and PGC-1α expression in pre and post intervention by the study groups in according to different models.
Gene | Time point | Selenium (n = 50) | Placebo (n = 50) | Mean difference (95% CI) | Cohen's d (95% CI) | p value | Adjusted R2 | Adjusted p value‡ | Adjusted p value§ |
---|---|---|---|---|---|---|---|---|---|
SIRT1 | Pre | 0.863 ± 0.149 | 0.972 ± 0.285 | - | - | 0.512* | - | - | - |
Post | 1.573 ± 0.111 | 0.896 ± 0.109 | 0.67 (0.36–0.98) | 0.86 (0.45–1.27) | < 0.001† | 0.15 | < 0.001 | < 0.001 | |
PGC-1α | Pre | 1.102 ± 0.866 | 1.110 ± 0.131 | - | - | 0.964* | - | - | - |
Post | 1.352 ± 0.102 | 1.141 ± 0.100 | 0.21 (−0.07–0.49) | 0.29 (−0.10–0.68) | 0.146† | 0.42 | 0.148 | 0.149 |
Data presented as mean ± standard deviation.
PGC-1α, peroxisome proliferator-activated receptor γ coactivator-1α; SIRT1, silent information regulator 1; CI, confidence interval; ANOVA, analysis of variance; ANCOVA, analysis of covariance.
*Calculated based on independent t-test; †Calculated based on ANOVA model; ‡Adjusted for potential covariate (the baseline value, age) (calculated based on ANOVA/ANCOVA model); §Adjusted for potential covariate (the baseline value, colitis groups) (calculated based on ANOVA/ANCOVA model).